Cancer BiologyJournal of Medical VirologyPeer-reviewed
PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis
Lisa Beatrice Caruso, Giorgia Napoletani, Samantha S. Soldan…·Italo Tempera
This study shows that PARP1 inhibition reduces EBV-driven lymphoma progression by disrupting the EBNA2/MYC axis in a mouse model.
6 citations